A Review of Randomized Controlled Trials of Hereditary Angioedema Long-Term Prophylaxis with C1 Inhibitor Replacement Therapy: Alleviation of Disease Symptoms Is Achievable.

"Disclosure HL has consulted for, acted as speaker for, or collaborated in research with the following: Adverum, BioCryst, CSL Behring, GSK, Intellia, Ionis, KalVista, Pharming, Pharvaris, and Takeda. She also reports potential research collaboration with Astria. AV has received consultancy/speaker honoraria/meeting sponsorship from, or collaborated in research with, Pharming Group NV, Takeda/Shire, Sobi, CSL Behring, Pharvaris, and Ionis."

"Support for technical editorial and medical writing assistance was provided by Pharming Group NV, Leiden, the Netherlands. The authors did not receive any compensation for development of this manuscript. Pharming Group NV did not actively contribute to the content or have a role in the decision to submit but reviewed the article for scientific accuracy."